PRESENTATION

Q3 FY2024 — Presentation

Q3 FY2024PDF · 16 pages712 KB
Fiscal Year 2024, Third Quarter
January 26, 2024
EARNINGS CALL
PRESENTATION

-- 1 of 16 --

2
HORACIO ROZANSKI
President and Chief Executive Officer
MATT CALDERONE
Chief Financial Officer
NATHAN RUTLEDGE
Director & Head of Investor Relations
CALL
PARTICIPANTS

-- 2 of 16 --

3
DISCLAIMER
Forward Looking Safe Harbor Statement
Certain statements contained in this presentation and in related comments by our management include “forward-looking statements” within the meaning of the Private Securities
Litigation Reform Act of 1995. Examples of forward-looking statements include information concerning Booz Allen’s preliminary financial results, financial outlook and guidance, including
forecasted revenue, Adjusted EBITDA, Diluted EPS, Adjusted Diluted EPS, future quarterly dividends, and future improvements in operating margins, as well as any other statement that
does not directly relate to any historical or current fact. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “could,” “should,” “forecasts,”
“expects,” “intends,” “plans,” “anticipates,” “projects,” “outlook,” “believes,” “estimates,” “predicts,” “potential,” “continue,” “preliminary,” or the negative of these terms or other
comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will
prove to have been correct.
These forward-looking statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our
actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these
forward-looking statements. A number of important factors could cause actual results to differ materially from those contained in or implied by these forward-looking statements,
including those factors discussed in our filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the fiscal year ended March 31, 2023,
which can be found at the SEC’s website at www.sec.gov. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the
foregoing cautionary statements. All such statements speak only as of the date made and, except as required by law, we undertake no obligation to update or revise publicly any forward-
looking statements, whether as a result of new information, future events or otherwise.
Note Regarding Non-GAAP Financial Data Information
Booz Allen discloses Revenue, Excluding Billable Expenses, Adjusted Operating Income, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue,
Excluding Billable Expenses, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, Free Cash Flow Conversion, and Net Leverage Ratio, which are not recognized measurements
under accounting principles generally accepted in the United States, or GAAP, and when analyzing Booz Allen’s performance or liquidity, as applicable, investors should (i) evaluate each
adjustment in our reconciliation of revenue to Revenue, Excluding Billable Expenses, operating income to Adjusted Operating Income, net income attributable to common stockholders to
Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses, Adjusted Net Income and Adjusted Diluted EPS, and net cash
provided by operating activities to Free Cash Flow and Free Cash Flow Conversion, and net debt to Net Leverage Ratio and the explanatory footnotes regarding those adjustments, each as
defined under GAAP, (ii) use Revenue, Excluding Billable Expenses, Adjusted Operating Income, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on
Revenue, Excluding Billable Expenses, Adjusted Net Income, and Adjusted Diluted EPS in addition to, and not as an alternative to, revenue, operating income, net income attributable to
common stockholders or diluted EPS, as measures of operating results, each as defined under GAAP, (iii) use Free Cash Flow, Free Cash Flow Conversion, and Net Leverage Ratio, in
addition to, and not as an alternative to, net cash provided by operating activities as a measure of liquidity, each as defined under GAAP, and (iv) use Net Leverage Ratio in addition to, and
not as an alternative to, net debt as a measure of Booz Allen's debt leverage. The Appendix includes a reconciliation of Revenue, Excluding Billable Expenses, Adjusted Operating Income,
Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, Free
Cash Flow Conversion, and Net Leverage Ratio to the most directly comparable financial measure calculated and presented in accordance with GAAP. Booz Allen presents these
supplemental performance measures because it believes that these measures provide investors and securities analysts with important supplemental information with which to evaluate
Booz Allen’s performance, long term earnings potential, or liquidity, as applicable, and to enable them to assess Booz Allen’s performance on the same basis as management. These
supplemental performance and liquidity measurements may vary from and may not be comparable to similarly titled measures by other companies in Booz Allen’s industry. With respect
to our expectations under “Financial Outlook”, reconciliation of Adjusted Diluted EPS guidance, Adjusted EBITDA, and Adjusted EBITDA Margin on Revenue to the closest corresponding
GAAP measure is not available without unreasonable efforts on a forward-looking basis due to our inability to predict our stock price, equity grants and dividend declarations with respect
to Adjusted Diluted EPS, and our net income, net interest and other expenses with respect to Adjusted EBITDA and Adjusted EBITDA Margin on Revenue, during the course of fiscal 2024.
With respect to Adjusted Diluted EPS guidance, projecting future stock price, equity grants and dividends to be declared would be necessary to accurately calculate the difference between
Adjusted Diluted EPS and GAAP EPS as a result of the effects of the two-class method and related possible dilution used in the calculation of EPS. Consequently, any attempt to disclose
such reconciliation would imply a degree of precision that could be confusing or misleading to investors. We expect the variability of the above charges to have an unpredictable, and
potentially significant, impact on our future GAAP financial results. For the same reason, a reconciliation of Adjusted EBITDA and Adjusted EBITDA Margin on Revenue guidance for fiscal
2024 and 2025 and of Adjusted EBITDA guidance through fiscal 2025 to the closest corresponding GAAP measures are not available without unreasonable efforts on a forward-looking
basis due to our inability to predict specific quantifications of the amounts that would be required to reconcile such measures. Accordingly, Booz Allen is relying on the exception provided
by Item 10(e)(1)(i)(B) of Regulation S-K to exclude these reconciliations.

-- 3 of 16 --

4
KEY FINANCIAL RESULTS
THIRD QUARTER FISCAL YEAR 2024 RESULTS
(1) Comparisons are to prior fiscal year period.
(2) Reconciliations of Adjusted EBITDA and Adjusted EBITDA Margin on Revenue can be found on Slide 12. Net Income attributable to common stockholders was $145.6 million and $477.8 million for the three and nine months ended
December 31, 2023, respectively. Net income margin attributable to common stockholders was 5.7% and 6.0% for the three and nine months ended December 31, 2023, respectively.
THIRD QUARTER (1) FISCAL YEAR-TO-DATE (12/31/23) (1)
Revenue $2.6 billion +12.9% $7.9 billion +15.6%
Revenue, Excluding Billable Expenses $1.8 billion +13.0% $5.5 billion +14.7%
Net Income $146 million +374.6% $478 million +40.7%
Adjusted EBITDA2 $291 million +19.1% $888 million +13.5%
Adjusted EBITDA Margin on Revenue2 11.3% +5.6% 11.3% (1.7)%
Adjusted Net Income $184 million +29.4% $547 million +16.0%
Diluted EPS $1.11 +382.6% $3.62 +42.5%
Adjusted Diluted EPS $1.41 +31.8% $4.17 +17.5%
Net Cash Provided by Operating Activities $234 million 68.8% $115 million (68.5)%

-- 4 of 16 --

INVESTMENT THESIS
EXCEPTIONAL SHAREHOLDER VALUE CREATION
FY2023–FY2025 GOALS
Competitive
Edge at the
Mission-
Innovation
Intersection
ADJUSTED EBITDA
GROWTH TO $1.2–1.3B
Disciplined
Capital
Deployment
$2.0–3.5B
Organic
Revenue
5–8%
Strategic
Acquisitions &
Investments
Strong Mid 10%
Adjusted
EBITDA Margin
+ +

-- 5 of 16 --

6
KEY FINANCIAL RESULTS
THIRD QUARTER FISCAL YEAR 2024 RESULTS
THIRD QUARTER (1) FISCAL YEAR-TO-DATE (12/31/23) (1)
Revenue $2.6 billion +12.9% $7.9 billion +15.6%
Revenue, Excluding Billable Expenses $1.8 billion +13.0% $5.5 billion +14.7%
Net Income $146 million +374.6% $478 million +40.7%
Adjusted EBITDA2 $291 million +19.1% $888 million +13.5%
Adjusted EBITDA Margin on Revenue2 11.3% +5.6% 11.3% (1.7)%
Adjusted Net Income $184 million +29.4% $547 million +16.0%
Diluted EPS $1.11 +382.6% $3.62 +42.5%
Adjusted Diluted EPS $1.41 +31.8% $4.17 +17.5%
Net Cash Provided by Operating Activities $234 million 68.8% $115 million (68.5)%
Page 4 intentionally repeated
(1) Comparisons are to prior fiscal year period.
(2) Reconciliations of Adjusted EBITDA and Adjusted EBITDA Margin on Revenue can be found on Slide 12. Net Income attributable to common stockholders was $145.6 million and $477.8 million for the three and nine months ended
December 31, 2023, respectively. Net income margin attributable to common stockholders was 5.7% and 6.0% for the three and nine months ended December 31, 2023, respectively.

-- 6 of 16 --

7
$22.0
HISTORICAL BACKLOG & BOOK-TO-BILL
(1) For more information on the components of backlog, and the differences between backlog and remaining performance obligations, please see the Company's Form 10-K for the fiscal year ended March 31, 2023; totals may not sum due to rounding.
BACKLOG ($ IN BILLIONS) (1)
BOOK-TO-BILL TRENDS
$24.0 $26.8 $29.0 	$27.8 	$29.2 	$28.6
$31.8 $30.0 	$31.2 	$31.3
$35.0 	$34.3
$3.5 	$3.5 	$4.9 	$4.0 	$3.7 	$4.0 	$5.5 	$4.5 	$4.6 	$4.9 	$6.3 	$5.2
$6.1 	$9.0 	$9.5 	$9.4 	$9.9 	$10.0 	$10.4 	$10.1 	$9.5 	$9.0 $10.1 	$9.2
$14.4 $14.3 $14.6 	$14.3 	$15.6 	$14.6 $16.0 	$15.4 	$17.1 	$17.3
$18.6 	$19.9
Funded 	Unfunded 	Priced Options
4Q21 	1Q22 	2Q22 	3Q22 	4Q22 	1Q23 	2Q23 	3Q23 	4Q23 	1Q24 	2Q24 	3Q24
1.38x
1.30x
2.03x
0.39x
1.66x
0.72x
2.40x
0.09x
1.47x
1.03x
2.41x
0.72x
1.42x
1.20x
1.28x 	1.28x
1.36x
1.21x 	1.32x 	1.22x
1.18x
1.24x 	1.29x 1.41x
Quarterly Book-to-Bill 	LTM Book-to-Bill
4Q21 	1Q22 	2Q22 	3Q22 	4Q22 	1Q23 	2Q23 	3Q23 	4Q23 	1Q24 	2Q24 	3Q24
0.0x
1.0x
2.0x
3.0x

-- 7 of 16 --

8
CAPITAL ALLOCATION
DELIVERING STRONG CAPITAL RETURNS THROUGH EFFICIENT CAPITAL DEPLOYMENT
STRATEGY
– Our multi-year capital deployment plan follows a disciplined and opportunistic approach, subject to market conditions
– In Q3 FY 2024, we deployed approximately $164.2 million:
– $61.7 million through quarterly dividends;
– $94.5 million through share repurchases; and
– $8.1 million through strategic investments and acquisitions
– The Board authorized a dividend of $0.51 per share payable on March 1, 2024 to stockholders of record on February 12, 2024
– Share repurchase authorization capacity is $583.2 million available as of December 31, 2023
– Our capital allocation priorities remain: operating needs, quarterly dividend, strategic M&A, share repurchases, and debt repayment
HISTORICAL CAPITAL DEPLOYMENT ($ IN MILLIONS)(1)
QUARTERLY CAPITAL DEPLOYMENT ($ IN MILLIONS)(1)
$510.2
$191.5 	$179.5 $147.9 $164.2
$57.3 	$62.5 	$63.0 	$62.1 	$61.7
$10.8
$125.7 	$112.4 	$80.8 	$94.5
$442.1
$3.2 	$4.0 $5.0 	$8.1
Quarterly Dividends 	Share Repurchases 	M&A
3Q23 	4Q23 	1Q24 	2Q24 	3Q24
$333.2
$571.3
$1,493.9
$905.0
$683.0
$146.6 	$181.1 	$209.1 	$235.7 	$249.3
$186.6
$318.1 $419.3 $224.0
$413.4
$—
$72.2
$865.5
$445.3 	$20.3
Quarterly Dividends 	Share Repurchases 	M&A
FY20 	FY21 	FY22 	FY23 	LTM
(3)
(1) Totals may not sum due to rounding.
(2) Includes share repurchases transacted but not settled and paid.
(3) Represents payments for strategic investments, net of cash acquired.
(2) (3) (2)

-- 8 of 16 --

9
FINANCIAL OUTLOOK
FULL YEAR FISCAL 2024 GUIDANCE(1)
OPERATING PERFORMANCE Updated Fiscal Year 2024
Guidance Prior Fiscal Year 2024
Guidance
Revenue Growth 14.0% – 15.0% 11.0% – 14.0%
Adjusted EBITDA $1,155 – $1,175 million $1,115 – $1,145 million
Adjusted EBITDA Margin on Revenue ~11% High 10% to 11%
Adjusted Diluted EPS $5.25 – $5.40 $4.95 – $5.10
Updated Net Cash Provided by Operating Activities(2) $200 – $275 million $160 – $260 million
(1) Reconciliations omitted in reliance on Item 10(e)(1)(i)(B) of Regulation S-K. See "Disclaimer."
(2) Reflects estimated net impact of settlement with the Department of Justice.
KEY ASSUMPTIONS Updated Fiscal Year 2024
Assumptions Prior Fiscal Year 2024
Assumptions
Inorganic Revenue Contributions ~1.0% ~1.0%
Effective Tax Rate 22% – 23% 23% – 25%
Average Diluted Shares Outstanding 129 – 131 million 129 – 131 million
Interest Expense $170 – $180 million $170 – $180 million
Depreciation and Amortization ~$165 million ~$165 million
Cash Taxes Related to Section 174 ~$125 million ~$100 million
Capital Expenditures $75 – $95 million $75 – $95 million

-- 9 of 16 --

10
APPENDIX

-- 10 of 16 --

11
NON-GAAP FINANCIAL INFORMATION
• “Revenue, Excluding Billable Expenses” represents revenue less billable expenses. Booz Allen uses Revenue, Excluding Billable Expenses because it
provides management useful information about the Company’s operating performance by excluding the impact of costs that are not indicative of the level
of productivity of its client staff headcount and its overall direct labor, which management believes provides useful information to its investors about its
core operations.
• “Adjusted Operating Income” represents operating income before the change in provision for claimed indirect costs, acquisition and divestiture costs,
financing transaction costs, significant acquisition amortization, and the reserve associated with the U.S. Department of Justice investigation disclosed in
Note 15 to the Condensed Consolidated Financial Statements in the Company's Form 10-Q for the quarter ended December 31, 2023. Booz Allen prepares
Adjusted Operating Income to eliminate the impact of items it does not consider indicative of ongoing operating performance due to their inherent
unusual, extraordinary or non-recurring nature or because they result from an event of a similar nature.
• “Adjusted EBITDA” represents net income (loss) attributable to common stockholders before income taxes, net interest and other expense and
depreciation and amortization and before certain other items, including the change in provision for claimed indirect costs, acquisition and divestiture
costs, financing transaction costs, and the reserve associated with the U.S. Department of Justice investigation disclosed in Note 15 to the Condensed
Consolidated Financial Statements in the Company's Form 10-Q for the quarter ended December 31, 2023, and restructuring costs. “Adjusted EBITDA
Margin on Revenue” is calculated as Adjusted EBITDA divided by revenue. “Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses” is calculated
as Adjusted EBITDA divided by Revenue, Excluding Billable Expenses. Booz Allen prepares Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, and
Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses to eliminate the impact of items it does not consider indicative of ongoing operating
performance due to their inherent unusual, extraordinary or non-recurring nature or because they result from an event of a similar nature.
• “Adjusted Net Income” represents net income attributable to common stockholders before: (i) the change in provision for claimed indirect costs, (ii)
acquisition and divestiture costs, (iii) financing transaction costs, (iv) significant acquisition amortization, (v) the reserve associated with the U.S.
Department of Justice investigation disclosed in Note 15 to the Condensed Consolidated Financial Statements in the Company's Form 10-Q for the quarter
ended December 31, 2023, (vi) gains associated with divestitures or deconsolidation, and (vii) amortization and write-off of debt issuance costs and debt
discount, in each case net of the tax effect where appropriate calculated using an assumed effective tax rate. Booz Allen prepares Adjusted Net Income to
eliminate the impact of items, net of tax, it does not consider indicative of ongoing operating performance due to their inherent unusual, extraordinary or
non-recurring nature or because they result from an event of a similar nature. Booz Allen views Adjusted Net Income as an important indicator of
performance consistent with the manner in which management measures and forecasts the Company's performance and the way in which management is
incentivized to perform.
• “Adjusted Diluted EPS” represents diluted EPS calculated using Adjusted Net Income as opposed to net income. Additionally, Adjusted Diluted EPS does
not contemplate any adjustments to net income as required under the two-class method as disclosed in the footnotes to the consolidated financial
statements of the Company's Form 10-K for the fiscal year ended March 31, 2023.
• "Free Cash Flow" represents the net cash generated from operating activities less the impact of purchases of property, equipment and software. "Free
Cash Flow Conversion" is calculated as Free Cash Flow divided by Adjusted Net Income.
• "Net Leverage Ratio" is calculated as net debt (total debt less cash) divided by Adjusted EBITDA over the prior twelve months.

-- 11 of 16 --

12
NON-GAAP FINANCIAL INFORMATION (Unaudited)
Three Months Ended
December 31, Nine Months Ended
December 31,
(In thousands, except share and per share data) 2023 2022 2023 2022
Revenue, Excluding Billable Expenses
Revenue $ 2,569,801 $ 2,277,074 $ 7,890,569 $ 6,825,650
Less: Billable expenses 799,896 710,526 2,436,988 2,069,733
Revenue, Excluding Billable Expenses* $ 1,769,905 $ 1,566,548 $ 5,453,581 $ 4,755,917
Adjusted Operating Income
Operating Income $ 247,558 $ 58,640 $ 748,965 $ 489,756
Change in provision for claimed indirect costs (a) — — (18,345) —
Acquisition and divestiture costs (b) 1,952 19,096 5,480 40,121
Financing transaction costs (c) — — 820 6,888
Significant acquisition amortization (d) 13,597 14,101 40,301 36,275
Legal matter reserve (e) — 124,000 27,453 124,000
Adjusted Operating Income $ 263,107 $ 215,837 $ 804,674 $ 697,040
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue & Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses
Net income attributable to common stockholders $ 145,644 $ 30,997 $ 477,750 $ 340,213
Income tax expense 61,740 10,539 156,291 103,286
Interest and other, net (f) 40,174 17,412 114,924 46,907
Depreciation and amortization 41,113 42,046 123,867 121,200
EBITDA 288,671 100,994 872,832 611,606
Change in provision for claimed indirect costs (a) — — (18,345) —
Acquisition and divestiture costs (b) 1,952 19,096 5,480 40,121
Financing transaction costs (c) — — 820 6,888
Legal matter reserve (e) — 124,000 27,453 124,000
Adjusted EBITDA $ 290,623 $ 244,090 $ 888,240 $ 782,615
Net income margin attributable to common stockholders 5.7 % 1.4 % 6.1 % 5.0 %
Adjusted EBITDA Margin on Revenue 11.3 % 10.7 % 11.3 % 11.5 %
Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses 16.4 % 15.6 % 16.3 % 16.5 %
12
* Revenue, Excluding Billable Expenses includes $18.3 million of revenue resulting from the reduction to our provision for claimed indirect costs as noted on slide 14.

-- 12 of 16 --

13
NON-GAAP FINANCIAL INFORMATION (Unaudited)
Three Months Ended
December 31, Nine Months Ended
December 31,
Adjusted Net Income
Net income attributable to common stockholders $ 145,644 $ 30,997 $ 477,750 $ 340,213
Change in provision for claimed indirect costs (a) — — (18,345) —
Acquisition and divestiture costs (b) 1,952 19,096 5,480 40,121
Financing transaction costs (c) — — 820 6,888
Significant acquisition amortization (d) 13,597 14,101 40,301 36,275
Legal matter reserve (e) — 124,000 27,453 124,000
Gains associated with divestitures or deconsolidation (g) — (13,472) — (44,632)
Amortization or write-off of debt issuance costs and debt discount 1,062 780 2,950 5,780
Adjustments for tax effect (h) 22,048 (33,020) 10,094 (37,518)
Adjusted Net Income $ 184,303 $ 142,482 $ 546,503 $ 471,127
Adjusted Diluted Earnings Per Share
Weighted-average number of diluted shares outstanding $ 130,489,050 $ 132,759,877 $ 131,058,754 $ 132,831,569
Diluted earnings per share $ 1.11 $ 0.23 $ 3.62 $ 2.54
Adjusted Net Income Per Diluted Share (i) $ 1.41 $ 1.07 $ 4.17 $ 3.55
Free Cash Flow
Net cash provided by operating activities 233,985 138,582 115,068 365,674
Less: Purchases of property, equipment and software (23,096) (21,664) (50,532) (51,398)
Free Cash Flow $ 210,889 $ 116,918 $ 64,536 $ 314,276
Operating cash flow conversion 161 % 447 % 24 % 107 %
Free cash flow conversion 114 % 82 % 12 % 67 %
13

-- 13 of 16 --

14
NON-GAAP FINANCIAL INFORMATION (Unaudited)
(a) Represents the reduction to our provision for claimed indirect costs recorded during the second quarter of fiscal 2024, which resulted in a
corresponding increase to revenue, as a result of the Defense Contract Audit Agency's findings related to its audit of our claimed indirect costs for fiscal
2022. See Note 15, "Commitments and Contingencies," to the condensed consolidated financial statements in the Company's Form 10-Q for the quarter
ended December 31, 2023 for further information.
(b) Represents costs associated with the acquisition efforts of the Company related to transactions for which the Company has entered into a letter of
intent to acquire a controlling financial interest in the target entity, as well as the divestiture costs incurred in divesting a portion of our business.
Acquisition and divestiture costs primarily include costs associated with (i) buy-side and sell-side due diligence activities, (ii) compensation expenses
associated with employee retention, and (iii) legal and advisory fees, primarily associated with the acquisitions of Liberty IT Solutions, LLC (“Liberty”) and
Tracepoint Holdings, LLC (“Tracepoint”) in fiscal 2022, and the acquisition of EverWatch Corp. (“EverWatch”) and the divestitures of our management
consulting business serving the Middle East and North Africa (“MENA”) and our Managed Threat Services business (“MTS”) in fiscal 2023. See Note 5,
“Acquisition, Goodwill and Intangible Assets,” to the condensed consolidated financial statements in the Company's Form 10-Q for the quarter ended
December 31, 2023 for further information.
(c) Reflects expenses associated with debt financing activities incurred during the second quarters of fiscal 2024 and 2023.
(d) Amortization expense associated with acquired intangibles from significant acquisitions. Significant acquisitions include acquisitions which the
Company considers to be beyond the scope of our normal operations. Significant acquisition amortization includes amortization expense associated with
the acquisition of Liberty in the second quarter of fiscal 2022 and EverWatch in the third quarter of fiscal 2023.
(e) Reserve associated with the U.S. Department of Justice's investigation of the Company. See Note 15, “Commitments and Contingencies,” to the
condensed consolidated financial statements in the Company's Form 10-Q for the quarter ended December 31, 2023 for further information.
(f) Reflects the combination of Interest expense and Other income, net from the condensed consolidated statement of operations.
(g) Represents the gain recognized on the divestitures of the Company's MENA business in the second quarter of fiscal 2023, its MTS business in the third
quarter of fiscal 2023, and the gain on the deconsolidation of an artificial intelligence software platform business in the third quarter of fiscal 2023.
(h) Reflects the tax effect of adjustments at an assumed effective tax rate of 26%, which approximates the blended federal and state tax rates, and
consistently excludes the impact of other tax credits and incentive benefits realized. The tax effect of certain discrete items is calculated specifically and
may vary from the general 26% rate. The tax effect also includes the indirect effects of uncertainty around the application of Section 174 of the Tax Cuts
and Jobs Act of 2017 ($26.0 million and $22.0 million for the three and nine months ended December 31, 2023, respectively). See Note 10, “Income
Taxes,” to the condensed consolidated financial statements in the Company's Form 10-Q for the quarter ended December 31, 2023 for further
information.
(i) Excludes adjustments of approximately $1.2 million and $3.9 million of net earnings for the three and nine months ended December 31, 2023,
respectively, and approximately $0.5 million and $2.6 million of net earnings for the three and nine months ended December 31, 2022, respectively,
associated with the application of the two-class method for computing diluted earnings per share.
14

-- 14 of 16 --

15
NON-GAAP FINANCIAL INFORMATION (Unaudited)
(In thousands, except share and per share data) Three Months Ended
December 31, 2023 Three Months Ended
September 30, 2023 Three Months Ended
June 30, 2023 Three Months Ended
March 31, 2023
Net income (loss) attributable to common
stockholders $ 145,644 $ 170,718 $ 161,388 $ (68,422)
Income tax (benefit) expense 61,740 55,071 39,480 (6,552)
Interest and other, net (a) 40,174 41,200 33,550 31,992
Depreciation and amortization 41,113 40,907 41,847 44,284
EBITDA $ 288,671 $ 307,896 $ 276,265 $ 1,302
Change in provision for claimed indirect costs (b) — (18,345) — —
Acquisition and divestiture costs (c) 1,952 260 3,268 4,148
Financing transaction costs (d) — 820 — —
Legal matter reserve (e) — — 27,453 226,000
Adjusted EBITDA $ 290,623 $ 290,631 $ 306,986 $ 231,450
Last 12 months Adjusted EBITDA $ 1,119,690
Total Debt $ 3,421,106
Less: Cash 601,813
Net Debt $ 2,819,293
Net Leverage Ratio (g) 2.5
Three Months Ended
December 31, 2022 Three Months Ended
September 30, 2022 Three Months Ended
June 30, 2022 Three Months Ended
March 31, 2022
Net income attributable to common stockholders $ 30,997 $ 170,932 $ 138,284 $ 90,873
Income tax expense 10,539 51,258 41,489 33,897
Interest and other, net (a) 17,412 1,882 27,613 23,653
Depreciation and amortization 42,046 39,052 40,102 40,824
EBITDA $ 100,994 $ 263,124 $ 247,488 $ 189,247
Acquisition and divestiture costs (c) 19,096 15,932 5,093 11,670
Financing transaction costs (d) — 6,888 — —
Legal matter reserve (e) 124,000 — — —
Restructuring costs (f) — — — 4,164
Adjusted EBITDA $ 244,090 $ 285,944 $ 252,581 $ 205,081
Last 12 months Adjusted EBITDA $ 987,696
Total Debt $ 2,821,711
Less: Cash 370,939
Net Debt $ 2,450,772
Net Leverage Ratio (g) 2.5 15
(a) Reflects the combination of Interest expense
and Other income, net from the condensed
consolidated statement of operations.
(b) Represents the reduction to our provision for
claimed indirect costs recorded during the second
quarter of fiscal 2024, which resulted in a
corresponding increase to revenue, as a result of
the Defense Contract Audit Agency's findings
related to its audit of our claimed indirect costs
for fiscal 2022. See Note 15, "Commitments and
Contingencies," to the condensed consolidated
financial statements in the Company's Form 10-Q
for the quarter ended December 31, 2023 for
further information.
(c) Represents costs associated with the
acquisition efforts of the Company related to
transactions for which the Company has entered
into a letter of intent to acquire a controlling
financial interest in the target entity, as well as
the divestiture costs incurred in divesting a
portion of our business. Acquisition and
divestiture costs primarily include costs
associated with (i) buy-side and sell-side due
diligence activities, (ii) compensation expenses
associated with employee retention, and (iii)
legal and advisory fees primarily associated with
the acquisitions of Liberty and Tracepoint in fiscal
2022, and the acquisition of EverWatch and the
divestitures of our MENA business and MTS
business in fiscal 2023. See Note 5, "Acquisition,
Goodwill and Intangible Assets," to the
condensed consolidated financial statements in
the Company's Form 10-Q for the quarter ended
December 31, 2023 for further information.
(d) Reflects expenses associated with debt
financing activities incurred during the second
quarters of fiscal 2024 and 2023.
(e) Reserve associated with the U.S. Department
of Justice's investigation of the Company. See
Note 15, "Commitments and Contingencies," to
the condensed consolidated financial statements
in the Company's Form 10-Q for the quarter
ended December 31, 2023 for further
information.
(f) Represents restructuring charges of $8.3
million incurred during the fourth quarter of fiscal
2022, net of approximately $4.2 million of
revenue recognized on recoverable expenses,
associated with severance costs of a
restructuring plan to reduce certain executive
administrative personnel costs.
(g) "Net Leverage Ratio" is calculated as net debt
(total debt less cash) divided by Adjusted EBITDA
over the prior twelve months.

-- 15 of 16 --

16
FINANCIAL RESULTS – KEY DRIVERS
Third Quarter Fiscal 2024 – Below is a summary of the key factors driving results for the fiscal 2024 third quarter ended December 31,
2023 as compared to the prior year period:
• Revenue increased 12.9% to $2.6 billion and Revenue, Excluding Billable Expenses increased 13.0% to $1.8 billion. Revenue growth
was primarily driven by strong demand for our services and solutions as well as continued headcount growth.
• Operating income increased 322.2% to $247.6 million and Adjusted Operating Income increased 21.9% to $263.1 million. The
increase was primarily driven by the same drivers benefiting revenue growth as well as strong contract-level performance coupled
with ongoing cost management efforts. In addition, fiscal 2023 operating income was negatively impacted by a $124.0 million reserve
associated with the U.S. Department of Justice's investigation of the Company recorded in the third quarter. The increase in Adjusted
Operating Income was driven by the same factors impacting operating income with the exception of the aforementioned legal matter
reserve, which did not impact Adjusted Operating Income.
• Net income increased 374.6% to $145.6 million and net income attributable to common stockholders increased 369.9% to $145.6
million. These changes were primarily driven by the same factors as operating income, partially offset by a net gain in the prior year of
$8.9 million from the de-consolidation of an artificial intelligence software platform business, and a $4.6 million pre-tax gain
associated with the divestiture of the Company's Managed Threat Services business. In addition, an increase in the provision for
income taxes associated with the reversal of an uncertain tax position related to Section 174 of the Tax Cuts and Jobs Act of 2017 had
a negative impact on net income. Adjusted Net Income increased 29.4% to $184.3 million. The change in Adjusted Net Income was
primarily driven by the same factors as Adjusted Operating Income, as well as higher interest expense.
• EBITDA increased 185.8% to $288.7 million and Adjusted EBITDA increased 19.1% to $290.6 million. These changes were due to the
same factors as operating income and Adjusted Operating Income, respectively.
• Diluted EPS increased to $1.11 from $0.23 and Adjusted Diluted EPS increased to $1.41 from $1.07. The changes were primarily
driven by the same factors as net income and Adjusted Net Income, respectively, partially offset by a lower share count in the third
quarter of fiscal 2024.
• Net cash used in operating activities was $234.0 million for the quarter ended December 31, 2023, as compared to $138.6 million in
the prior year. Free Cash Flow was $210.9 million for the quarter ended December 31, 2023, as compared to $116.9 million in the
prior year. Operating cash was aided by strong collection performance and overall revenue growth.

-- 16 of 16 --